Molecular Pathogenesis of Hereditary Lung Cancer: a Literature Review

References

• Bray F , FerlayJ , SoerjomataramI , SiegelRL , TorreLA , JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68(6), 394–424 (2018).
   PubMed Web of Science ®Google Scholar
• Musolf AM , SimpsonCL , de AndradeMet al. Familial lung cancer: a brief history from the earliest work to the most recent studies. Genes (Basel)8(1), 36 (2017).
   PubMed Web of Science ®Google Scholar
• Kanwal M , DingX-J , CaoY. Familial risk for lung cancer. Oncol Lett.13(2), 535–542 (2017).
   PubMed Web of Science ®Google Scholar
• Dai J , LvJ , ZhuM , WangY , QinN , MaHet al. Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations. Lancet Respir. Med.7(10), 881–891 (2019).
   PubMed Web of Science ®Google Scholar
• Gazdar A , RobinsonL , OliverDet al. Hereditary lung cancer syndrome targets never smokers with germline EGFR gene T790M mutations. J. Thorac. Oncol.9(4), 456–463 (2014).
   PubMed Web of Science ®Google Scholar
• Tokuhata GK , LilienfeldAM. Familial aggregation of lung cancer among hospital patients. Public Health Rep.78, 277–283 (1963).
   PubMed Web of Science ®Google Scholar
• Coté ML , LiuM , BonassiSet al. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur. J. Cancer48(13), 1957–1968 (2012).
   PubMed Web of Science ®Google Scholar
• Timofeeva MN , McKayJD , SmithGDet al. Genetic polymorphisms in 15q25 and 19q13 loci, cotinine levels, and risk of lung cancer in EPIC. Cancer Epidemiol. Biomarkers Prev.20(10), 2250–2261 (2011).
   PubMed Web of Science ®Google Scholar
• Yamamoto H , YatabeY , ToyookaS. Inherited lung cancer syndromes targeting never smokers. Transl. Lung Cancer Res.7(4), 498–504 (2018).
   PubMed Web of Science ®Google Scholar
• Wang Y , BroderickP , MatakidouA , EisenT , HoulstonRS. Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers. Carcinogenesis31(2), 234–238 (2010).
   PubMed Web of Science ®Google Scholar
• Lan Q , HsiungCA , MatsuoKet al. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat. Genet.44(12), 1330–1335 (2012).
   PubMed Web of Science ®Google Scholar
• Hung RJ , SpitzMR , HoulstonRSet al. Lung cancer risk in never-smokers of european descent is associated with genetic variation in the 5p15.33 TERT-CLPTM1Ll region. J. Thorac. Oncol.14(8), 1360–1369 (2019).
   PubMed Web of Science ®Google Scholar
• Seow WJ , MatsuoK , HsiungCAet al. Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations. Hum. Mol. Genet.26(2), 454–465 (2017).
   PubMed Web of Science ®Google Scholar
• Hu Z , WuC , ShiYet al. A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat. Genet.43(8), 792–796 (2011).
   PubMed Web of Science ®Google Scholar
• Shao L , ZuoX , YangYet al. The inherited variations of a p53-responsive enhancer in 13q12.12 confer lung cancer risk by attenuating TNFRSF19 expression. Genome Biol.20(1), 103 (2019).
   PubMedGoogle Scholar
• G Fehringer , PKraft , PD Pharoahet al. Cross-cancer genome-wide analysis of lung, ovary, breast, prostate, and colorectal cancer reveals novel pleiotropic associations. Cancer Res. Cancer Res.76(17), 5103–5114 (2016).
   PubMed Web of Science ®Google Scholar
• Wang Y , McKayJD , RafnarTet al. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat. Genet.46(7), 736–741 (2014).
   PubMed Web of Science ®Google Scholar
• Byun J , SchwartzAG , LuskCet al. Genome-wide association study of familial lung cancer. Carcinogenesis39(9), 1135–1140 (2018).
   PubMed Web of Science ®Google Scholar
• Musolf AM , MoizBA , SunHet al. Whole exome sequencing of highly aggregated lung cancer families reveals linked loci for increased cancer risk on chromosomes 12q, 7p, and 4q. Cancer Epidemiol. Biomarkers Prev.29(2), 434–442 (2020).
   PubMed Web of Science ®Google Scholar
• Musolf AM , SimpsonCL , de AndradeM et al. Parametric linkage analysis identifies five novel genome-wide significant loci for familial lung cancer. Hum. Hered.82(1–2), 64–74 (2016).
   PubMed Web of Science ®Google Scholar
• Jiang X , FinucaneHK , SchumacherFRet al. Shared heritability and functional enrichment across six solid cancers. Nat. Commun.10(1), 431 (2019).
   PubMedGoogle Scholar
• Lou Y , PecotCV , TranHTet al. Germline mutation of T790M and dual/multiple EGFR mutations in patients with lung adenocarcinoma. Clin. Lung Cancer17(2), e5–e11 (2016).
   PubMedGoogle Scholar
• Ikeda K , NomoriH , MoriT , SasakiJ , KobayashiT. Novel germline mutation: EGFR V843I in patient with multiple lung adenocarcinomas and family members with lung cancer. Ann. Thorac. Surg.85(4), 1430–1432 (2008).
   PubMed Web of Science ®Google Scholar
• Matsushima S , OhtsukaK , OhnishiHet al. V843I, a lung cancer predisposing EGFR mutation, is responsible for resistance to EGFR tyrosine kinase inhibitors. J. Thorac. Oncol.9(9), 1377–1384 (2014).
   PubMed Web of Science ®Google Scholar
• Prim N , LegrainM , GuerinEet al. Germ-line exon 21 EGFR mutations, V843I and P848L, in non-small-cell lung cancer patients. Eur. Respir. Rev.23(133), 390–392 (2014).
   PubMedGoogle Scholar
• Tibaldi C , GiovannettiE , VasileEet al. Inherited germline T790M mutation and somatic epidermal growth factor receptor mutations in non-small cell lung cancer patients. J. Thoracic Oncol.6(2), 395–396 (2011).
   PubMed Web of Science ®Google Scholar
• Thomas A , XiL , CarterCA et al. Concurrent molecular alterations in tumors with germ line epidermal growth factor receptor T790M mutations. Clin. Lung Cancer14(4), 452–456 (2013).
   PubMed Web of Science ®Google Scholar
• Yu HA , ArcilaME , HarlanFleischut Met al. Germline EGFR T790M mutation found in multiple members of a familial cohort. J. Thorac. Oncol.9(4), 554–558 (2014).
   PubMed Web of Science ®Google Scholar
• Centeno I , BlayP , SantamaríaIet al. Germ-line mutations in epidermal growth factor receptor (EGFR) are rare but may contribute to oncogenesis: a novel germ-line mutation in EGFR detected in a patient with lung adenocarcinoma. BMC Cancer11, 172 (2011).
   PubMed Web of Science ®Google Scholar
• van Noesel J , vander Ven WH , van OsTAMet al. Activating germline R776H mutation in the epidermal growth factor receptor associated with lung cancer with squamous differentiation. JCO.31(10), e161–164 (2013).
   PubMed Web of Science ®Google Scholar
• Lu S , YuY , LiZet al. EGFR and ERBB2 germline mutations in Chinese lung cancer patients and their roles in genetic susceptibility to cancer. J. Thorac. Oncol.14(4), 732–736 (2019).
   PubMed Web of Science ®Google Scholar
• Hu Y , AldenRS , OdegaardJIet al. Discrimination of germline EGFR T790M mutations in plasma cell-free DNA allows study of prevalence across 31,414 cancer patients. Clin. Cancer Res.23(23), 7351–7359 (2017).
   PubMed Web of Science ®Google Scholar
• Liu T-C , JinX , WangY , WangK. Role of epidermal growth factor receptor in lung cancer and targeted therapies. Am. J. Cancer Res.7(2), 187–202 (2017).
   PubMed Web of Science ®Google Scholar
• Pros E , SaigiM , AlamedaDet al. Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors. Ann. Oncol.31(2), 274–282 (2020).
   PubMed Web of Science ®Google Scholar
• Haddad FG , KourieHR , KattanJ. Targeting EGFR mutation in non-small-cell lung cancer: challenges and future perspectives. Future Oncol.13(3), 201–204 (2017).
   PubMed Web of Science ®Google Scholar
• Cedrés S , FelipE , CruzCet al. Activity of HSP90 inhibiton in a metastatic lung cancer patient with a germline BRCA1 mutation. J. Natl Cancer Inst.110(8), 914–917 (2018).
   PubMedGoogle Scholar
• Cytryn S , MoreiraA , ChachouaA , SabariJ. Common germline mutations in a patient with multiple primary lung cancers. Clin. Lung Cancer21(3), e212–215 (2020).
   PubMed Web of Science ®Google Scholar
• Sanchis-Borja M , FalletV , BenusiglioPet al. Mutations germinales de BRCA et cancer bronchopulmonaire (CBP): à propos de 9 cas. Revue des Maladies Respiratoires Actualités.12(1), 48 (2020).
   Google Scholar
• Canney A , SheahanK , KeeganD , TolanM , HylandJ , GreenA. Synchronous lung tumours in a patient with metachronous colorectal carcinoma and a germline MSH2 mutation. J. Clin. Pathol.62(5), 471–473 (2009).
   PubMed Web of Science ®Google Scholar
• Fang W , QiuF , ZhangLet al. The functional polymorphism of NBS1 p.Glu185Gln is associated with an increased risk of lung cancer in Chinese populations: case-control and a meta-analysis. Mutat. Res.770, 61–68 (2014).
   PubMed Web of Science ®Google Scholar
• Helgadottir H , HöiomV , JönssonGet al. High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families. J. Med. Genet.51(8), 545–552 (2014).
   PubMed Web of Science ®Google Scholar
• Chen H-Y , YuS-L , HoB-Cet al. R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability. J. Clin. Oncol.33(20), 2303–2310 (2015).
   PubMed Web of Science ®Google Scholar
• Xiong D , WangY , KupertEet al. A recurrent mutation in PARK2 is associated with familial lung cancer. Am. J. Hum. Genet.96(2), 301–308 (2015).
   PubMed Web of Science ®Google Scholar
• Nathan N , GiraudV , PicardCet al. Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer. Hum. Mol. Genet.25(8), 1457–1467 (2016).
   PubMed Web of Science ®Google Scholar
• Tode N , KikuchiT , SakakibaraTet al. Exome sequencing deciphers a germline MET mutation in familial epidermal growth factor receptor-mutant lung cancer. Cancer Sci.108(6), 1263–1270 (2017).
   PubMed Web of Science ®Google Scholar
• Krishnaswamy S , KantetiR , Duke-CohanJSet al. Ethnic differences and functional analysis of MET mutations in lung cancer. Clin. Cancer Res.15(18), 5714–5723 (2009).
   PubMed Web of Science ®Google Scholar
• T Wang , HLiu , SXiao , RMao , RLin . MUC16 germline mutations may predispose inherited cancer family members to lung adenocarcinomas. J. Clin. Oncol.37(Suppl. 15), e13039 (2020).
   Web of Science ®Google Scholar
• Parry EM , GableDL , StanleySEet al. Germline mutations in DNA repair genes in lung adenocarcinoma. J. Thorac. Oncol.12(11), 1673–1678 (2017).
   PubMed Web of Science ®Google Scholar
• Ji X , MukherjeeS , LandiMTet al. Protein-altering germline mutations implicate novel genes related to lung cancer development. Nat. Commun.11(1), 2220 (2020).
   PubMed Web of Science ®Google Scholar
• Tian P , ChengX , ZhaoZet al. Spectrum of pathogenic germline mutations in chinese lung cancer patients through next-generation sequencing. Pathol. Oncol. Res.26(1), 109–114 (2020).
   PubMed Web of Science ®Google Scholar
• Zhang Z-L , WangN-N , MaQ-Let al. Somatic and germline mutations in the tumor suppressor gene PARK2 impair PINK1/Parkin-mediated mitophagy in lung cancer cells. Acta Pharmacol. Sin.41(1), 93–100 (2020).
   PubMed Web of Science ®Google Scholar
• Kanwal M , DingX-J , MaZ-Het al. Characterization of germline mutations in familial lung cancer from the Chinese population. Gene641, 94–104 (2018).
   PubMed Web of Science ®Google Scholar
• Donner I , KatainenR , SipiläLJ , AavikkoM , PukkalaE , AaltonenLA. Germline mutations in young non-smoking women with lung adenocarcinoma. Lung Cancer122, 76–82 (2018).
   PubMed Web of Science ®Google Scholar
• Peng L , ZengZ , TengXet al. Genomic profiling of synchronous triple primary tumors of the lung, thyroid and kidney in a young female patient: a case report. Oncol. Lett.16(5), 6089–6094 (2018).
   PubMed Web of Science ®Google Scholar
• Couto PP , Bastos-RodriguesL , SchayekHet al. Spectrum of germline mutations in smokers and nonsmokers in Brazilian non-small-cell lung cancer (NSCLC) patients. Carcinogenesis38(11), 1112–1118 (2017).
   PubMed Web of Science ®Google Scholar
• Yoneda K , ImanishiN , IchikiY , TanakaF. Treatment of non-small cell lung cancer with EGFR-mutations. J. UOEH41(2), 153–163 (2019).
   PubMedGoogle Scholar
• Zhao J , XiaY. Targeting HER2 alterations in non–small-cell lung cancer: a comprehensive review. JCO Precision Oncol. (4), 411–25 (2020).
   PubMedGoogle Scholar
• Wolf J , SetoT , HanJ-Yet al. Capmatinib in MET exon 14-mutated or MET-amplified non-small-cell lung cancer. N. Engl. J. Med.383(10), 944–957 (2020).
   PubMed Web of Science ®Google Scholar
• Cook SA , TinkerAV. PARP inhibitors and the evolving landscape of ovarian cancer management: a review. BioDrugs33(3), 255–273 (2019).
   PubMed Web of Science ®Google Scholar
• Litton JK , RugoHS , EttlJet al. Talazoparib in patients with advanced breast cancer and a germline BRCA mutation. N. Engl. J. Med.379(8), 753–763 (2018).
   PubMed Web of Science ®Google Scholar
• de Bono J , MateoJ , FizaziKet al. Olaparib for metastatic castration-resistant prostate cancer. N. Engl. J. Med.382(22), 2091–2102 (2020).
   PubMed Web of Science ®Google Scholar
• Golan T , HammelP , ReniMet al. Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer. N. Engl. J. Med.381(4), 317–327 (2019).
   PubMed Web of Science ®Google Scholar
• de Bono J , RamanathanRK , MinaLet al. Phase I, dose-escalation, two-part trial of the PARP inhibitor talazoparib in patients with advanced germline BRCA1/2 mutations and selected sporadic cancers. Cancer Discov.7(6), 620–629 (2017).
   PubMed Web of Science ®Google Scholar
• W Ji , XWeng , DXu , SCai , HLou , LDing. Non-small cell lung cancer cells with deficiencies in homologous recombination genes are sensitive to PARP inhibitors. Biochem. Biophys. Res. Commun.522(1), 121–126 (2020).
   PubMed Web of Science ®Google Scholar
• Kadouri L , RottenbergY , ZickAet al. Homologous recombination in lung cancer, germline and somatic mutations, clinical and phenotype characterization. Lung Cancer137, 48–51 (2019).
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman MH , PilarskiR , CebullaCMet al. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J. Med. Genet.48(12), 856–859 (2011).
   PubMed Web of Science ®Google Scholar
• Kobrinski DA , YangH , KittanehM. BAP1: role in carcinogenesis and clinical implications. Transl. Lung Cancer Res.9(Suppl. 1), S60–S66 (2020).
   PubMedGoogle Scholar
• Laderian B , MundiP , FojoT , EBates S. Emerging therapeutic implications of STK11 mutation: case series. Oncologist25(9), 733–737 (2020).
   PubMed Web of Science ®Google Scholar
• Zhuang X , LiY , CaoHet al. Case report of a Li-Fraumeni syndrome-like phenotype with a de novo mutation in CHEK2. Medicine (Baltimore)95(29), e4251 (2016).
   PubMed Web of Science ®Google Scholar
• Wu C , XuB , YuanPet al. Genome-wide examination of genetic variants associated with response to platinum-based chemotherapy in patients with small-cell lung cancer. Pharmacogenet. Genomics20(6), 389–395 (2010).
   PubMed Web of Science ®Google Scholar
• Liu Y , LiuP , WenWet al. Haplotype and cell proliferation analyses of candidate lung cancer susceptibility genes on chromosome 15q24-25.1. Cancer Res.69(19), 7844–7850 (2009).
   PubMed Web of Science ®Google Scholar
• Oudkerk M , DevarajA , VliegenthartRet al. European position statement on lung cancer screening. Lancet Oncol.18(12), e754–766 (2017).
   PubMed Web of Science ®Google Scholar
• Wood DE , KazerooniEA , BaumSLet al. Lung cancer screening, Version 3.2018, NCCN clinical practice guidelines in oncology. J. National Comprehensive Cancer Network16(4), 412–441 (2018).
   PubMed Web of Science ®Google Scholar